11/09/2019 | Point of view
If there were any doubts about Apple's efforts in entering the field of healthcare well beyond that of a technology and platform provider, this article about three groundbreaking health studies they are launching in Women’s Health, Heart and Movement, and Hearing should put them aside for good.
The main question for the pharma industry however is how much data from their own digital health innovation efforts to cede to companies like Apple, Google and Amazon by building digital health solutions that (must) rely on these providers who will routinely capture, store (and perhaps interpret) their data, or how much to build solutions around technologies that they can more closely manage and control.
One does not need to look too far back in time to see how Apple created a common data platform (iTunes), use it to learn user habits and essentially lock them onto it, only to kill all the competition (MP3 player manufacturers) that those very same users were relying upon. This move essentially catapulted the iPod music player, and its evolution to a device that came to be known as the iPhone. Is this history going to repeat itself in the world of health?
One of the things that Healthware Labs does with our clients is to help assess factors like these in the digital health solutions that we identify, design and build in partnership with them. We are happy to talk to current and prospective customers about their digital health plans, and give our viewpoint on the approach.